TECVAYLI™ is a prescription medicine to treat adults with multiple myeloma who have already received at least 4 treatment regimens, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody to treat their multiple myeloma, and their cancer has come back or did not respond to prior treatment.

For US Patients Only

For Healthcare Providers
Sign Up for Updates
Prescribing Information Medication Guide
Back to Home

Contact Us

Thank you for your interest in contacting Janssen Biotech, Inc. Please note that we can only provide information about products marketed within the United States, and must refer international inquiries to our affiliates.

Janssen will be happy to answer any general product-related questions. However, we cannot recommend treatment or offer medical advice on personal health matters. If you have a question that relates to treatment of a personal medical condition, please contact your physician or healthcare professional, as this individual is most familiar with your specific medical condition and complete medical history.

If you require immediate assistance or wish to report a side effect or product complaint, Janssen Medical Information can be reached by phone at 1-800-JANSSEN (1-800-526-7736), Monday–Friday, 9 AM to 8 PM ET.

card icon

Phone

Please call: 1-800-JANSSEN (1-800-526-7736)

Monday–Friday, 9 AM to 8 PM ET.

card icon

Mail

If you prefer to correspond with us via regular mail, or have inquiries regarding vendor opportunities or marketing/product suggestions, please use the following address:

Janssen Scientific Affairs Medical Information Center

PO Box 200

Titusville, NJ 08560

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.fda.gov/medwatch or call 1-800-FDA-1088.